Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Journal of Opioid Management
|
December 19, 2019
Key characteristics and habits of the recreational opioid user
Anna Schinas, Shein Nanji, Kira Vorobej, et al.
Drugs in R&D
|
September 10, 2011
Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users
Lynn R Webster, Franklin K Johnson, Joseph Stauffer, et al.
Clinical and Translational Science
|
September 9, 2021
The bioequivalence of fixed-dose combination tablets of bisoprolol and ramipril and its drug-drug interaction potential
Jan Sus, Jade Huguet, Jan Bosak, et al.
Journal of Opioid Management
|
January 9, 2018
Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users
Beatrice Setnik, Kerri Schoedel, Cindy Bartlett, et al.
Journal of Opioid Management
|
May 20, 2016
Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients
Christopher Sankey, Beatrice Setnik, Zoltan Harsanyi, et al.
Pain Research & Management
|
August 13, 2013
Assessing the subjective and physiological effects of intranasally administered crushed extended-release morphine formulations with and without a sequestered naltrexone core in recreational opioid users
Beatrice Setnik, Veeraindar Goli, Naama Levy-Cooperman, et al.
Current Medical Research and Opinion
|
March 10, 2017
The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain
Beatrice Setnik, Carl L Roland, Alexandra I Barsdorf, et al.
Psychopharmacology
|
February 7, 2023
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Journal of Pain Research
|
November 18, 2011
Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting
James Brown, Beatrice Setnik, Keung Lee, et al.
Journal of Clinical Psychopharmacology
|
June 24, 2022
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users
Ishani Landry, Nancy Hall, Jagadeesh Alur, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Journal of Opioid Management
|
December 19, 2019
Key characteristics and habits of the recreational opioid user
Anna Schinas, Shein Nanji, Kira Vorobej, et al.
Drugs in R&D
|
September 10, 2011
Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users
Lynn R Webster, Franklin K Johnson, Joseph Stauffer, et al.
Clinical and Translational Science
|
September 9, 2021
The bioequivalence of fixed-dose combination tablets of bisoprolol and ramipril and its drug-drug interaction potential
Jan Sus, Jade Huguet, Jan Bosak, et al.
Journal of Opioid Management
|
January 9, 2018
Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users
Beatrice Setnik, Kerri Schoedel, Cindy Bartlett, et al.
Journal of Opioid Management
|
May 20, 2016
Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients
Christopher Sankey, Beatrice Setnik, Zoltan Harsanyi, et al.
Pain Research & Management
|
August 13, 2013
Assessing the subjective and physiological effects of intranasally administered crushed extended-release morphine formulations with and without a sequestered naltrexone core in recreational opioid users
Beatrice Setnik, Veeraindar Goli, Naama Levy-Cooperman, et al.
Current Medical Research and Opinion
|
March 10, 2017
The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain
Beatrice Setnik, Carl L Roland, Alexandra I Barsdorf, et al.
Psychopharmacology
|
February 7, 2023
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Journal of Pain Research
|
November 18, 2011
Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting
James Brown, Beatrice Setnik, Keung Lee, et al.
Journal of Clinical Psychopharmacology
|
June 24, 2022
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users
Ishani Landry, Nancy Hall, Jagadeesh Alur, et al.
Page
of 6